This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IBM Plunges: What Wall Street's Saying (Update 1)


JPMorgan analyst Mark Moskowitz (Neutral, $175 PT)

"We expect shares of Neutral-rated IBM to be under pressure in the near term. The company's 4Q13 results were mixed, particularly when adjusting for the lower tax rate. Moreover, the 1Q14 EPS outlook of roughly $2.50 implies a big hill to climb to achieve IBM's full year EPS target of 'at least' $18. Prior to the earnings call, 1Q14 consensus and J.P. Morgan estimates had been $3.29 and $3.39."

Jefferies analyst Peter Misek (Hold, $190 PT)

"IBM recommits to $20 2015 EPS target while acknowledging the need to accelerate retooling and cost-cutting efforts. Software and Services were relative highlights; Hardware was the lowlight, especially China (again). We maintain our $18 2014 EPS est (in line with guidance) and $190 target."

Cantor Fitzgerald analyst Brian White (Buy, $220 PT)

"Last night, IBM reported 4Q:13 results that exceeded our projections, and the company provided what we consider a palatable 2014 EPS outlook, while maintaining its 2015 EPS projection. Although IBM warned of weak EPS performance in 1Q:14, this softness versus our estimate is driven by a restructuring charge that most tech companies would exclude from operating performance. Based on current estimates, our model now suggests that IBM's sales cycle bottomed in 4Q:13, and we are projecting the operating profit cycle to trough in 1Q:14, providing us with a view that the worst is over for IBM in the intermediate term. As such, we reiterate our BUY rating and $220.00 price target." -- Written by Chris Ciaccia in New York

>Contact by Email.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
IBM $160.67 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%
TSLA $206.79 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs